Cliftonlarsonallen Wealth Advisors LLC lifted its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 6.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 11,042 shares of the pharmacy operator’s stock after buying an additional 677 shares during the quarter. Cliftonlarsonallen Wealth Advisors LLC’s holdings in Walgreens Boots Alliance were worth $754,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also modified their holdings of WBA. Cornerstone Advisors Inc. grew its stake in Walgreens Boots Alliance by 102.4% in the third quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 214 shares in the last quarter. Alpha Omega Wealth Management LLC grew its stake in Walgreens Boots Alliance by 44.8% in the fourth quarter. Alpha Omega Wealth Management LLC now owns 869 shares of the pharmacy operator’s stock worth $59,000 after purchasing an additional 269 shares in the last quarter. Central Bank & Trust Co. bought a new position in Walgreens Boots Alliance in the fourth quarter worth approximately $98,000. BlueMountain Capital Management LLC bought a new position in Walgreens Boots Alliance in the second quarter worth approximately $103,000. Finally, Asset Dedication LLC boosted its position in Walgreens Boots Alliance by 204.6% during the 3rd quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock valued at $115,000 after acquiring an additional 1,060 shares in the last quarter. Hedge funds and other institutional investors own 62.93% of the company’s stock.
Walgreens Boots Alliance stock opened at $71.59 on Wednesday. The company has a quick ratio of 0.36, a current ratio of 0.80 and a debt-to-equity ratio of 0.44. The firm has a market capitalization of $68.33 billion, a PE ratio of 11.89, a price-to-earnings-growth ratio of 1.13 and a beta of 0.99. Walgreens Boots Alliance Inc has a 1-year low of $59.07 and a 1-year high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, December 20th. The pharmacy operator reported $1.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.43 by $0.03. The firm had revenue of $33.79 billion during the quarter, compared to analysts’ expectations of $33.90 billion. Walgreens Boots Alliance had a return on equity of 22.17% and a net margin of 3.96%. The business’s quarterly revenue was up 9.9% on a year-over-year basis. During the same quarter last year, the firm earned $1.28 EPS. As a group, equities research analysts expect that Walgreens Boots Alliance Inc will post 6.52 EPS for the current fiscal year.
Several analysts have issued reports on the company. Zacks Investment Research cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Monday, December 3rd. BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Wednesday, January 2nd. Robert W. Baird increased their target price on Walgreens Boots Alliance from $69.00 to $71.00 and gave the company a “neutral” rating in a research report on Friday, October 12th. UBS Group assumed coverage on Walgreens Boots Alliance in a research report on Thursday, January 17th. They set a “sell” rating and a $70.00 target price on the stock. Finally, SunTrust Banks increased their target price on Walgreens Boots Alliance to $75.00 and gave the company a “hold” rating in a research report on Friday, October 12th. Four investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $78.83.
In other news, SVP Kimberly R. Scardino sold 11,970 shares of the firm’s stock in a transaction on Thursday, November 1st. The stock was sold at an average price of $79.79, for a total value of $955,086.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Kathleen Wilson-Thompson sold 52,000 shares of the firm’s stock in a transaction on Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total value of $4,096,040.00. Following the completion of the sale, the executive vice president now directly owns 81,076 shares of the company’s stock, valued at approximately $6,386,356.52. The disclosure for this sale can be found here. Insiders sold a total of 73,756 shares of company stock valued at $5,824,194 in the last three months. Insiders own 15.73% of the company’s stock.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: Initial Public Offering (IPO)
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.